

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Probucol is an anti-hyperlipidemic drug by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism. |
| Concentration | Treated Time | Description | References | |
| Mesenchymal stem cells (MSCs) | 50, 100, 150 µM | 12 hours | To investigate the protective effect of probucol on MSCs under oxidative stress, results showed that probucol reversed H2O2-induced damage, improved cell viability, and reduced ROS production. | Stem Cell Res Ther. 2020 Jul 21;11(1):302 |
| MC3T3-E1 cells | 0.1 µM | 24 hours, 48 hours, 72 hours | To evaluate the effect of Probucol on the viability and function of MC3T3-E1 cells, the results showed that Probucol at 10 µM significantly improved cell viability and reduced H2O2-induced oxidative stress. | Mol Med. 2022 Jun 28;28(1):75 |
| Administration | Dosage | Frequency | Description | References | ||
| New Zealand White rabbits | Balloon-injured carotid artery model in cholesterol-fed rabbits | Oral | 1% | Continued for 5 weeks | To evaluate the effects of probucol on neointimal thickening and macrophage accumulation after balloon injury. Results showed that probucol significantly reduced serum cholesterol levels, inhibited neointimal thickening, and reduced macrophage accumulation. | Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11312-6 |
| SD rats | Bilateral ovariectomy (OVX)-induced osteoporosis model | Oral gavage | 1 mg/kg and 3.5 mg/kg | Once daily for 12 weeks | To evaluate the therapeutic effect of Probucol on osteoporosis in OVX rats, the results showed that Probucol significantly improved bone density and trabecular structure, and reduced oxidative stress-mediated abnormal bone metabolism. | Mol Med. 2022 Jun 28;28(1):75 |
| Mice | Pdss2 mutant mice | Oral | 1% w/w | From weaning through at least 6 months of age or for 3 weeks prior to typical nephritis onset | Probucol significantly ameliorated focal segmental glomerulopathy-like kidney disease in Pdss2 mutant animals, restored CoQ9 content in mutant kidney, and mitigated transcriptional alterations across many intermediary metabolic domains, including peroxisome proliferator-activated receptor (PPAR) pathway signaling. | EMBO Mol Med. 2011 Jul;3(7):410-27 |
| Sprague-Dawley rats | Diabetic mellitus-induced erectile dysfunction (DMED) model | Oral | 500 mg/kg/day | Once daily for 4 weeks | To evaluate the effect of probucol combined with MSCs in the treatment of diabetic erectile dysfunction, results showed that the combination therapy significantly improved erectile function, reduced fibrosis, and increased endothelial function. | Stem Cell Res Ther. 2020 Jul 21;11(1):302 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT03753555 | Stroke, Ischemic ... 展开 >> Atherosclerosis, Cerebral 收起 << | Phase 4 | Not yet recruiting | November 30, 2021 | - |
| NCT00598533 | Coronary Heart Disease | Phase 4 | Completed | - | Germany ... 展开 >> Medizinische Klinik, Klinikum rechts der Isar Muenchen, Germany, 81675 Deutsches Herzzentrum Muenchen Munich, Germany, 80636 收起 << |
| NCT00276133 | Chronic Nephropathy | Phase 4 | Completed | - | Japan ... 展开 >> Yokohama City University Center Hospital Yokohama, Kanagawa, Japan, 232-0024 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.93mL 0.39mL 0.19mL |
9.67mL 1.93mL 0.97mL |
19.35mL 3.87mL 1.93mL |
|
| CAS号 | 23288-49-5 |
| 分子式 | C31H48O2S2 |
| 分子量 | 516.84 |
| SMILES Code | CC(SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1)(SC2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2)C |
| MDL No. | MFCD00079281 |
| 别名 | DH-581; Lorelco; Hoechst Brand of Probucol; Superlipid; Lurselle; Lesterol; Bisphenabid; Biphenabid; NSC 652160; NSC 86225 |
| 运输 | 蓝冰 |
| InChI Key | FYPMFJGVHOHGLL-UHFFFAOYSA-N |
| Pubchem ID | 4912 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(203.16 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1